TY  - GEN 
AU  - Ramos, S. M.
AU  - Gil Calvo, Marta
AU  - Roldan, V.
AU  - Martinez, A. C.
AU  - Santos, F.
PY  - 2020
SN  - 2296-2360
UR  - http://hdl.handle.net/20.500.11940/16685
AB  - X-linked hypophosphatemia (XLH) causes significant burden in pediatric patients in spite of maintained treatment with phosphate supplements and vitamin D derivatives. Administration of burosumab has shown promising results in clinical trial but...
KW  - Rickets
KW  - Hypophosphatemia
KW  - Vitamin D
TI  - Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia
DO  - 10.3389/fped.2020.00048
KW  - CHUS
VL  - 8.
ER  -